AMBUJACEM Charts, Analysis and Tips

home > cement > ambujacem

Technical Analysis

Technical Strength: 5.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.5. According to RSI analysis, ambujacem is at it's support. 8.0 AMBUJACEM RSI Chart
MACD (?) MACD: 3.28 and Signal Line: 4.83. According to MACD analysis, ambujacem is marginally weak. 3.0 AMBUJACEM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, ambujacem is facing resistance at 235 and support level is at 220.894. 3.0 AMBUJACEM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, ambujacem is facing resistance from it's 20-day exponential moving average at 232.8274 and support level is at 230. 8.0 AMBUJACEM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.136. According to bollinger bands, ambujacem is technically weak. 3.0 AMBUJACEM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 226.6022 and 220.95. Resistance level is 244.9. 6.5 AMBUJACEM Fibonacci Retracement Chart
Average True Range (?) ATR: 5.69 NA AMBUJACEM Average True Range Chart
Average Directional Index (?) ADX is 31.6 which means AMBUJACEM is in a trend. NA AMBUJACEM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
February 27, 2017
Open Price 231.8
High Price 232.0
Low Price 226.6
Close Price 229.9
Absolute Change -2.1
Percentage Change -0.905%
Weekly Change -3.48%
Monthly Change -1.25%
Yearly Change 17.7%
52-week high 281.7
52-week low 185.0
Corporate Actions
ExDate Purpose
March 16, 2017 DIV - RS 1.20 PER SHARE
August 02, 2016 INT DIV-RS 1.60 PER SHARE
August 02, 2016 INTERIM DIVIDEND
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.979
Confidence in Beta15.7%
Market Capital Rs. 35631.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 27 February 2017: Deliverable Quantity:1.1e+06 NA AMBUJACEM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 27 February 2017: Daily Volatility:0.2808 NA AMBUJACEM Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 27 February 2017: PCR_OI:0.367 PCR:0.536 NA AMBUJACEM PCR Chart
Premium (?) 27 February 2017 Premium: -0.65 Futures OI:10280000.0 NA AMBUJACEM Premium Chart
Option_MAX_OI (?) 27 February 2017: Price:229.9 Put with maximum OI:230.0 Call with maximum OI:240.0 NA AMBUJACEM Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 30, 2017 229.25 10280000.0 1503.0 1605.0 229.9
April 27, 2017 230.1 57500.0 14.0 14.0 229.9

Option Chains - NSE



February 21, 2017 ADividendAmbuja Cements Limited has informed the Exchange that The Board of Directors has recommended a final dividend on Equity Shares at the rate of Rs. 1.20 per share With the interim dividend of Rs.1.60 per share paid during the year, the total dividend for the year 2016 works out to Rs. 2.80 per share. The Company in the previous year had paid dividend @ Rs.2.80 per share which included interim dividend.Rs.1.60 per share.
February 21, 2017 AAnalysts/Institutional Investor Meet/Con. Call UpdatesAmbuja Cements Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
See all Announcements

Board Meetings

Date Meeting Date Purpose
February 01, 2017 February 20, 2017 IResults/DividendInter alia, to consider and take on record the Audited Annual Financial Results for the Corporate Financial Year ended December 31, 2016 and to recommend final dividend on equity shares.
October 13, 2016 November 03, 2016 TResultsTo consider the Unaudited Financial Results for the Third Quarter ended September 30, 2016 of the Corporate Financial Year 2016.
See all Board Meetings

AMBUJACEM is part of...

Index Weightage
NIFTY 0.75
CNX100 0.63
CNX500 0.53

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 221.6 Rs. 224.1 Rs. 227 Rs. 229.5 Rs. 232.4 Rs. 234.9 Rs. 237.8